Senna Leaf Extract Powder

Senna Leaf Extract Powder is a concentrated botanical ingredient produced from the leaves of Senna alexandrina Mill., a Fabaceae species also widely identified in commercial sourcing as Cassia angustifolia. Unlike milled senna leaf, the extracted powder concentrates the characteristic hydroxyanthracene glycosides associated with the botanical, particularly the sennoside group used for ingredient identification and standardization.

Commercial formats include standardized extracts with 10% and 20% sennosides together with 10:1 ratio extract. The higher standardized grade is the primary specification for concentrated formulations, while 10% provides a lower-strength option. Ratio extract and standardized extract specifications represent different purchasing criteria and should not be treated as equivalent measures of sennoside concentration.

SKU: BOT-BEX-0562 Categories: Botanical Extracts, Leaf & Herb Extracts Tags: Anthraquinone Glycosides, Anthraquinones, Digestive Support, Leaf, Senna alexandrina, Senna Leaf, Sennosides

Ingredient Profile & Common Uses

Senna alexandrina leaf is the botanical starting material for this extract, with Cassia angustifolia Vahl and Cassia senna L. retained as important synonyms in botanical and pharmacopoeial terminology. The product is an extracted ingredient rather than simple ground leaf. This distinction is commercially important because extracts can be specified through marker standardization or extraction ratio, whereas whole botanical powder retains the naturally occurring constituent profile of the dried plant material.

Standardized grades are differentiated primarily through declared sennoside content. A 20% grade provides a concentrated format where controlled marker input and reduced ingredient mass are important, while 10% sennosides provides an alternative standardized level. A 10:1 extract follows a different specification logic: the ratio describes the relationship between botanical starting material and resulting extract and does not independently define the concentration of sennoside A, sennoside B, or total sennosides.

Senna leaf extract is primarily used in concentrated herbal, nutraceutical, and regulated botanical product systems. Its marker concentration makes accurate weighing and blend distribution more important than with simple leaf powder. Formulators should also consider its inherent botanical color and sensory contribution, particularly in exposed powder formats, while low-inclusion tablet and capsule systems require effective premixing to support batch homogeneity.

Application Areas

Capsules

Standardized senna leaf extract is used in capsule systems where a defined sennoside specification allows formulators to control botanical input while reducing extract mass compared with lower-strength material.

Tablets

The concentrated powder can be incorporated into tablet formulations designed around a defined botanical marker level. Premixing, powder flow, excipient compatibility, and compression performance should be evaluated during development.

Standardized Herbal Products

10% and 20% sennoside grades support herbal formulations requiring a declared marker concentration rather than relying only on the natural constituent variation of dried senna leaf.

Multi-Botanical Powder Blends

Ratio extracts and standardized grades can be incorporated into multi-ingredient botanical blends. Uniform distribution becomes particularly important when concentrated extract represents only a small proportion of the finished blend.

Typical Specifications

Parameter	Specification
Product Name	Senna Leaf Extract Powder
Botanical Name	Senna alexandrina Mill.
Commercial Botanical Synonym	Cassia angustifolia Vahl
Additional Synonym	Cassia senna L.
Botanical Family	Fabaceae
Plant Part	Leaf
Pharmacopoeial Botanical Term	Sennae folium
Ingredient Type	Standardized Botanical Extract / Ratio Extract
Product Form	Powder
Primary Standardized Grade	20% Sennosides
Secondary Standardized Grade	10% Sennosides
Ratio Extract	10:1
Primary Marker Compounds	Sennoside A · Sennoside B
Constituent Class	Hydroxyanthracene / Dianthrone Glycosides
Assay Reporting Formats	Total Sennosides · Sennosides A+B

Marker Compounds & Standardization

Sennoside A and sennoside B are the principal analytical markers associated with standardized senna extracts. They belong to the dianthrone glycoside group within the broader hydroxyanthracene-derivative profile of senna. Related constituents include sennosides C and D together with additional glycosidic compounds present in the botanical matrix.

For commercial sourcing, percentage alone is not sufficient to interpret a sennoside specification. A 20% extract may be reported as total sennosides calculated against a defined reference basis or as combined sennoside A+B content. UV spectrophotometric and chromatographic methods are both used in commercial specifications, but they do not necessarily report the same analytical quantity.

This distinction matters when comparing quotations. “20% total sennosides by UV” should not automatically be treated as analytically identical to “20% sennosides A+B by HPLC.” Procurement teams should therefore compare the marker definition and assay basis together with the declared concentration rather than purchasing on the headline percentage alone.

Technical & Quality Considerations

Botanical identity and marker definition are the first analytical priorities for Senna Leaf Extract Powder. Authentication should establish the Senna alexandrina leaf source and distinguish it from other Senna or Cassia materials. For standardized grades, analytical review should establish the declared marker definition and assay basis, while chromatographic profiling can provide additional information on constituent identity and extract composition.

Physical evaluation should focus on the actual extract grade rather than assuming all senna extracts behave alike. Marker concentration, extraction conditions, carrier use, and drying process can influence powder density, flow, dispersibility, color, and sensory impact. A standardized high-strength extract therefore should not automatically be assigned the same physical characteristics as a 10:1 ratio extract or a lower-strength standardized powder.

For dry-form scale-up, concentrated grades require careful control of ingredient distribution. Geometric dilution or staged premixing can improve uniformity when the extract is used at a relatively low inclusion level. Capsule projects should evaluate fill consistency and powder flow, while tablet development should assess blend uniformity, compression behavior, and excipient interaction using the actual commercial grade selected for production.

Packaging & Commercial Supply

Essencefield supports product evaluation, formulation trials, commercial orders, and ongoing ingredient supply. Packaging, storage, and shipping arrangements are determined by product characteristics, order quantity, stability requirements, and destination-market needs.

Supply Item	General Information
Sample	Available upon request for formulation, testing, and supplier evaluation
Order Quantities	100 g · 1 kg · 5 kg · 25 kg · 100 kg · 500 kg · Bulk
Sample Lead Time	Typically 5–7 days after sample confirmation
Production Lead Time	Typically 15–30 days after order and specification confirmation
Packaging	Suitable protective inner packaging with bags, cartons, drums, or other appropriate outer packaging
Storage	Store in tightly sealed, suitable protective packaging in a cool, dry environment. Protect from moisture, heat, and direct sunlight. Specific storage conditions follow the approved product specification.
Documentation	COA · Product Specification · TDS · SDS · Applicable declarations (as applicable)

Final order quantities, lead times, packaging, documentation, and shipping arrangements are confirmed according to the selected product and commercial requirements.